Mirae Asset Global Investments
AERI

Mirae Asset Global Investments’s Aerie Pharmaceuticals AERI Stock Holding History

Mirae Asset Global Investments’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35,026
Closed -$530K – 2658
2022
Q3 		$530K Buy
35,026
+1,965
+6% +$22.8K ﹤0.01% 1837
2022
Q2 		$248K Buy
+33,061
New +$233K ﹤0.01% 2074
2022
Q1 		– Sell
-10,673
Closed -$75K – 1664
2021
Q4 		$75K Buy
10,673
+241
+2% +$2.52K ﹤0.01% 1558
2021
Q3 		$119K Buy
+10,432
New +$152K ﹤0.01% 1719
2018
Q2 		– Sell
-27,108
Closed -$1.47M – 817
2018
Q1 		$1.47M Sell
27,108
-12,249
-31% -$685K 0.02% 437
2017
Q4 		$2.35M Buy
39,357
+27,257
+225% +$1.65M 0.03% 326
2017
Q3 		$588K Sell
12,100
-157
-1% -$8.57K 0.01% 514
2017
Q2 		$644K Buy
+12,257
New +$571K 0.01% 454

Mirae Asset Global Investments's AERI Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 35,026 shares — an estimated $530K sold.

Mirae Asset Global Investments first reported a position in AERI in Q2 2017 and held it in 8 quarters. The position peaked at $2.35M in Q4 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Mirae Asset Global Investments reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 35,026 Aerie Pharmaceuticals shares in Q4 2022, an estimated $530K.
  • Mirae Asset Global Investments first reported a position in Aerie Pharmaceuticals in Q2 2017 and held it in 8 quarters.
  • Mirae Asset Global Investments's Aerie Pharmaceuticals position peaked at $2.35M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.